These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30674687)

  • 101. The costs of treating vaginal and vulval cancer in England (2009-2015).
    Stephens S; Chatterjee A; Coles V; Crawford R
    BMC Public Health; 2020 Apr; 20(1):453. PubMed ID: 32252711
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States.
    Clay PA; Thompson TD; Markowitz LE; Ekwueme DU; Saraiya M; Chesson HW
    Vaccine; 2023 Mar; 41(14):2376-2381. PubMed ID: 36907737
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Treatment patterns and associated costs for genital warts in Italy.
    Merito M; Largeron N; Cohet C; Timelli L; Boselli F; Matteelli A; Naldi L; Vittori G
    Curr Med Res Opin; 2008 Nov; 24(11):3175-83. PubMed ID: 18851777
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Prevalence of Human Papillomavirus (HPV) DNA among Men with Oropharyngeal and Anogenital Cancers: A Systematic Review and Meta-Analysis.
    Sasidharanpillai S; Ravishankar N; Kamath V; Bhat PV; Bhatt P; Arunkumar G
    Asian Pac J Cancer Prev; 2021 May; 22(5):1351-1364. PubMed ID: 34048162
    [TBL] [Abstract][Full Text] [Related]  

  • 105. The cost of treating genital warts.
    Strauss MJ; Khanna V; Koenig JD; Downs SM; Goldberg SH; Manyak MJ; Patsner B
    Int J Dermatol; 1996 May; 35(5):340-8. PubMed ID: 8734656
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis.
    Fabiano G; Marcellusi A; Mennini FS; Sciattella P; Favato G
    Eur J Health Econ; 2023 Feb; 24(1):75-80. PubMed ID: 35551568
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Annual prevalence and economic burden of genital warts in Korea: Health Insurance Review and Assessment (HIRA) service data from 2007 to 2015.
    Park YJ; Kim JM; Lee BR; Kim TH; Lee EG
    Epidemiol Infect; 2018 Jan; 146(2):177-186. PubMed ID: 29235433
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers.
    Bjørge T; Dillner J; Anttila T; Engeland A; Hakulinen T; Jellum E; Lehtinen M; Luostarinen T; Paavonen J; Pukkala E; Sapp M; Schiller J; Youngman L; Thoresen S
    BMJ; 1997 Sep; 315(7109):646-9. PubMed ID: 9310566
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Health economic evaluation of topical treatments for external anogenital warts.
    Agbeci H; Rollot O; Derancourt C; Baglione Q; Benard A; Bertolotti A
    Ann Dermatol Venereol; 2024 Sep; 151(3):103288. PubMed ID: 39002407
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK.
    Woodhall SC; Jit M; Soldan K; Kinghorn G; Gilson R; Nathan M; Ross JD; Lacey CJ;
    Sex Transm Infect; 2011 Oct; 87(6):458-63. PubMed ID: 21636616
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Update on Recurrent Respiratory Papillomatosis.
    Derkay CS; Bluher AE
    Otolaryngol Clin North Am; 2019 Aug; 52(4):669-679. PubMed ID: 31078306
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Human papillomavirus-related genital disease in the immunocompromised host: Part II.
    Gormley RH; Kovarik CL
    J Am Acad Dermatol; 2012 Jun; 66(6):883.e1-17; quiz 899-900. PubMed ID: 22583721
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Economic burden of HPV9-related diseases: a real-world cost analysis from Italy.
    Mennini FS; Fabiano G; Favato G; Sciattella P; Bonanni P; Pinto C; Marcellusi A
    Eur J Health Econ; 2019 Aug; 20(6):829-840. PubMed ID: 30900047
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Evaluating the Strength of Association of Human Papillomavirus Infection With Penile Carcinoma: A Meta-Analysis.
    Catalfamo CJ; Brown HE; Dennis LK
    Sex Transm Dis; 2022 May; 49(5):368-376. PubMed ID: 35082241
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Should my son get an HPV vaccine?
    Stabb JE; Buckley R
    JAAPA; 2011 Jan; 24(1):53. PubMed ID: 21261150
    [No Abstract]   [Full Text] [Related]  

  • 116. The role of HPV in head and neck cancer and review of the HPV vaccine.
    D'Souza G; Dempsey A
    Prev Med; 2011 Oct; 53 Suppl 1(Suppl 1):S5-S11. PubMed ID: 21962471
    [TBL] [Abstract][Full Text] [Related]  

  • 117. The presentation of anogenital cancers as sexually transmissible infection: a case for vigilance.
    Markos AR
    Sex Health; 2007 Mar; 4(1):79-80. PubMed ID: 17382045
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Talking about human papillomavirus and cancer: development of consultation guides through lay and professional stakeholder coproduction using qualitative, quantitative and secondary data.
    Hendry M; Pasterfield D; Gollins S; Adams R; Evans M; Fiander A; Robling M; Campbell C; Bekkers MJ; Hiscock J; Nafees S; Rose J; Stanley M; Williams O; Makin M; Wilkinson C
    BMJ Open; 2017 Jun; 7(6):e015413. PubMed ID: 28652291
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Human papilloma virions in the laboratory.
    Dunne EF; Markowitz LE; Taylor LD; Unger ER; Wheeler CM
    J Clin Virol; 2014 Oct; 61(2):196-8. PubMed ID: 25088765
    [TBL] [Abstract][Full Text] [Related]  

  • 120. The economic burden of cervical cancer from diagnosis to one year after final discharge in Henan Province, China: A retrospective case series study.
    Wu Q; Jia M; Chen H; Zhang S; Liu Y; Prem K; Qian M; Yu H
    PLoS One; 2020; 15(5):e0232129. PubMed ID: 32379783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.